As of 2026-03-22, the Intrinsic Value of Revolution Medicines Inc (RVMD) is -23.16 USD. This RVMD valuation is based on the model Peter Lynch Fair Value. With the current market price of 95.78 USD, the upside of Revolution Medicines Inc is -124.18%.
Based on its market price of 95.78 USD and our intrinsic valuation, Revolution Medicines Inc (RVMD) is overvalued by 124.18%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -23.16 - -23.16 | -23.16 | -124.18% |
| P/E | (108.57) - (135.25) | (119.85) | -225.1% |
| DDM - Stable | (52.09) - (229.31) | (140.70) | -246.9% |
| DDM - Multi | (4.69) - (16.07) | (7.26) | -107.6% |
| Market Cap (mil) | 18,980.72 |
| Beta | 5.69 |
| Outstanding shares (mil) | 198.17 |
| Enterprise Value (mil) | 18,865.42 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.02% |
| Cost of Debt | 5.00% |
| WACC | 7.98% |